Clinical trials show progress in migraine frequency, skin cancer prevention
-
1:37
Wild Lights and Frosty Free Week: Milwaukee County Zoo shares...
-
3:18
There could be some showers for Christmas Eve
-
1:20
CBS 58’s One Good Thing: Northcott Neighborhood House distributes...
-
1:41
CBS 58’s Hometown Athlete: Steve Stricker talks Tiger, another...
-
2:51
Judge Hannah Dugan trial: Evidence released, courtroom audio...
-
2:33
Church of the Gesu back open and ready for Christmas Mass crowds
-
1:13
Man charged in hit-and-run that killed Watertown father of 3
-
1:59
’I’m not giving him up’: A woman’s fight to keep a wallaby...
-
2:01
More than 300 properties in Milwaukee have insufficient or no...
-
2:55
22-year-old man killed in Oak Creek shooting; police seek suspect
-
4:56
What to expect on I-41 and I-94 amid construction
-
0:41
Geyser waives revocation hearing after escaping group home
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.